Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $1.4 Million Registered Direct Offering
Press Release – New York, NY – November 14, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole placement agent in the registered direct offering of common stock securities of Onconova Therapeutics, Inc.
(NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). In connection with the offering, Onconova received approximately $1.4 million in gross proceeds from common stock sold at a price to the public of $1.50 per share.
The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Avital Perlman and associates Evan Berger and Ashley Jaber.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $5 Million Private Placement - February 12, 2018
- Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in $7.6 Million of Private Placements - February 8, 2018
- Sichenzia Ross Ference Kesner LLP Represents Roth Capital Partners and Brookline Securities in a $5.5 Million Public Offering of QBIO Med. - February 1, 2018